Pakistan Reviews Drug Pricing to Improve Public Access to Medicines

On 26 October, the Ministry of Economic Affairs reported that the government was prioritising public facilitation in its review of drug pricing, highlighting the importance of balancing medicine affordability with the sustainability of the pharmaceutical sector. No new healthcare project contract value or specific drug-price revision amount was disclosed in the announcement. Hospitals, pharmaceutical companies and healthcare providers can explore opportunities in medicine-supply analytics, digital patient systems and healthcare data management. HPC can support secure computing and data-driven healthcare operations; contact HPC for a quotation tailored to your requirements.

If you are interested to enquire further, please fill in the form below with your details and one of our consultants will contact you shortly.